⌘K

Home/Filings/4/0001437749-21-016510

4//SEC Filing

Adams Robert W 4

Accession 0001437749-21-016510

CIK 0001053691other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 9:41 PM ET

Size

13.6 KB

Accession

0001437749-21-016510

Insider Transaction Report

Form 4

Period: 2021-07-01

Diffusion Pharmaceuticals Inc.DFFN

Director

Transactions

Award
Stock Option (Right to Buy)
2021-07-01+83,300→ 83,300 total
Exercise: $0.72Exp: 2031-07-01→ Common Stock (83,300 underlying)

Footnotes (1)

[F1]The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021.

Documents

2 files

Issuer

Diffusion Pharmaceuticals Inc.

CIK 0001053691

Entity typeother

Related Parties

1

filerCIK 0001663144

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 9:41 PM ET
Size: 13.6 KB

View on SEC.gov